BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 9721528)

  • 1. [Vancomycin resistant enterococci].
    Fujita N; Komori T; Ike Y; Yoshimura M
    Rinsho Byori; 1998 Jul; 46(7):629-36. PubMed ID: 9721528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vancomycin resistant enterococci in Austria].
    Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vancomycin resistant enterococci in the Netherlands].
    Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
    Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.
    Deshpande LM; Fritsche TR; Moet GJ; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):163-70. PubMed ID: 17368801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics.
    Sakagami Y; Kajimura K; Wijesinghe WM; Dharmaratne HR
    Planta Med; 2002 Jun; 68(6):541-3. PubMed ID: 12094300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence and epidemiology of vancomycin-resistant enterococci in Australia.
    Bell J; Turnidge J; Coombs G; O'Brien F
    Commun Dis Intell; 1998 Oct; 22(11):249-52. PubMed ID: 9823687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal diversity of vancomycin-resistant enterococci from an outbreak in a tertiary care university hospital.
    Pearce CL; Evans MK; Peters SM; Cole MF
    Am J Infect Control; 1998 Dec; 26(6):563-8. PubMed ID: 9836839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of banning vancomycin analogue avoparcin on vancomycin-resistant enterococci in chicken farms in Taiwan.
    Lauderdale TL; Shiau YR; Wang HY; Lai JF; Huang IW; Chen PC; Chen HY; Lai SS; Liu YF; Ho M
    Environ Microbiol; 2007 Mar; 9(3):819-23. PubMed ID: 17298380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.
    Hagman HM; Strausbaugh LJ
    Postgrad Med; 1996 May; 99(5):60-5, 69-71. PubMed ID: 8650096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis.
    Pereira GH; Müller PR; Zanella RC; de Jesus Castro Lima M; Torchio DS; Levin AS
    Am J Infect Control; 2010 Jun; 38(5):406-9. PubMed ID: 20006408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital.
    Ergani-Ozcan A; Naas T; Baysan BO; Ogunc D; Inan D; Colak D; Nordmann P
    J Antimicrob Chemother; 2008 May; 61(5):1033-9. PubMed ID: 18319236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vancomycin-resistant enterococci (VRE)].
    Fujita N
    Rinsho Byori; 2000 Nov; 48(11):1036-43. PubMed ID: 11132557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands.
    Endtz HP; van den Braak N; van Belkum A; Kluytmans JA; Koeleman JG; Spanjaard L; Voss A; Weersink AJ; Vandenbroucke-Grauls CM; Buiting AG; van Duin A; Verbrugh HA
    J Clin Microbiol; 1997 Dec; 35(12):3026-31. PubMed ID: 9399488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular characterization of vancomycin-resistant enterococci isolates].
    Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic.
    Kolar M; Pantucek R; Vagnerova I; Sauer P; Kesselova M; Cekanova L; Koukalova D; Doskar J; Ruzickova V
    New Microbiol; 2006 Apr; 29(2):121-5. PubMed ID: 16841552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier].
    Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H
    Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.